Related Experiment Videos
Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion
1Department of Pharmacology, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Abstract:
The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion. Acute myocardial infarction was produced by tightening a previously placed loose silk loop around the coronary artery in conscious rats. Moxonidine (0.01, 0.03, or 0.10 mg/kg i.v., 10 min before coronary ligation) significantly decreased the incidence of ventricular tachycardia during the first 15 min of infarction (70 versus 100% in controls), and the number of animals that survived without developing any arrhythmia was increased (15, 20, and 25%, respectively, versus 0%). Reperfusion-induced arrhythmias were produced by releasing a snare after 6 min of myocardial ischemia in anesthetized, artificially ventilated rats. Reperfusion rapidly induced severe dysrhythmias in all of the control animals. Moxonidine pretreatment (0.03 and 0.10 mg/kg) decreased the incidence of ventricular fibrillation (25 and 30% versus 64%) and increased the number of animals that survived without developing any arrhythmia (20 and 25% versus 0%). We conclude that moxonidine offers significant protection against the development of arrhythmias induced by acute regional myocardial ischemia in conscious rats. Moxonidine pretreatment also provides a beneficial effect during reperfusion-induced arrhythmias that appear after a brief period of myocardial ischemia.
Insights
Moxonidine, an I1-imidazoline-receptor agonist, significantly reduced arrhythmias during myocardial infarction and reperfusion in rats. This drug offers protection against heart rhythm disturbances following acute ischemia.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Myocardial ischemia and reperfusion are major causes of cardiac arrhythmias.
- I1-imidazoline-receptor agonists are known for their cardiovascular effects.
- Moxonidine is a representative I1-imidazoline-receptor agonist.
Purpose of the Study:
- To investigate the antiarrhythmic effects of moxonidine.
- To assess moxonidine's influence on ischemia- and reperfusion-induced arrhythmias.
- To evaluate moxonidine's protective potential in a rat model of myocardial infarction.
Main Methods:
- Acute myocardial infarction induced by coronary artery ligation in conscious rats.
- Reperfusion-induced arrhythmias modeled by releasing a snare after ischemia in anesthetized rats.
- Administration of moxonidine intravenously at varying doses before interventions.
Main Results:
- Moxonidine significantly decreased the incidence of ventricular tachycardia during infarction.
- Moxonidine increased survival rates without arrhythmias during ischemia.
- Moxonidine reduced the incidence of ventricular fibrillation during reperfusion.
- Moxonidine improved survival rates without arrhythmias during reperfusion.
Conclusions:
- Moxonidine provides significant protection against arrhythmias induced by acute regional myocardial ischemia.
- Moxonidine exhibits beneficial effects on reperfusion-induced arrhythmias.
- Moxonidine demonstrates antiarrhythmic properties in the context of myocardial ischemia and reperfusion.